Hepatitis C virus infection and interferon therapy in patients with Down syndrome.

about

Direct Acting Antivirals in Patients with Chronic Hepatitis C and Down Syndrome.Pegylated interferon for hepatitis C virus infection in Down syndrome.

P2860

Q40450401-B66E1CDD-DE67-47EB-BA6E-391C9C1F125C Q51181794-0EE31328-E2DD-4498-B846-EF8796F5C16B

P2860

Hepatitis C virus infection and interferon therapy in patients with Down syndrome.

Item

http://www.wikidata.org/entity/Q54683078

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Hepatitis C virus infection and interferon therapy in patients with Down syndrome.

@en

Hepatitis C virus infection and interferon therapy in patients with Down syndrome.

@nl

type

Item

label

Hepatitis C virus infection and interferon therapy in patients with Down syndrome.

@en

Hepatitis C virus infection and interferon therapy in patients with Down syndrome.

@nl

prefLabel

Hepatitis C virus infection and interferon therapy in patients with Down syndrome.

@en

Hepatitis C virus infection and interferon therapy in patients with Down syndrome.

@nl

P1476

Hepatitis C virus infection and interferon therapy in patients with Down syndrome.

@en

P2093

Hitoshi Tajiri

http://www.w3.org/2001/XMLSchema#string

Keiichi Ozono

http://www.w3.org/2001/XMLSchema#string

Mariko Okaniwa

http://www.w3.org/2001/XMLSchema#string

Sousuke Terasawa

http://www.w3.org/2001/XMLSchema#string

Tomoo Fujisawa

http://www.w3.org/2001/XMLSchema#string

Toshiyuki Iizuka

http://www.w3.org/2001/XMLSchema#string

Yoko Miyoshi

http://www.w3.org/2001/XMLSchema#string

P2860

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

Favorable response to lymphoblastoid interferon-alpha in children with chronic hepatitis C.

Hepatitis B and C in institutions for individuals with intellectual disability.

An analysis of published trials of interferon monotherapy in children with chronic hepatitis C.

Use and interpretation of virological tests for hepatitis C.

Antigenicities of Group I and II hepatitis C virus polypeptides--molecular basis of diagnosis.

Immune dysfunction in Down's syndrome: primary immune deficiency or early senescence of the immune system?

Quantitation of hepatitis C virus RNA by competitive polymerase chain reaction.

A second-generation method of genotyping hepatitis C virus by the polymerase chain reaction with sense and antisense primers deduced from the core gene.

Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon.

P304

7-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1442-200X.2007.02515.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18279197

http://www.w3.org/2001/XMLSchema#string

Hepatitis C virus infection and interferon therapy in patients with Down syndrome.

about

P2860

P2860

Hepatitis C virus infection and interferon therapy in patients with Down syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698